References

J. Storopoli. Bayesian Statistics with Julia and Turing. (2021).

P. McCullagh and J. Nelder. Generalized Linear Models, Second Edition. Chapman \& Hall (1989).

A. Hald. Maximum likelihood estimation of the parameters of a normal distribution which is truncated at a known point. Scandinavian Actuarial Journal 1949, 119–134 (1949).

S. L. Beal. Ways to fit a PK model with some data below the quantification limit. Journal of pharmacokinetics and pharmacodynamics 28, 481–504 (2001).

. On the error of the Laplace approximation when lags and duration parameters have between-subject variation. Volume 31 of , A Coruña, Spain (2023).

R. Savic, D. Jonker, T. Kerbusch and M. Karlsson. Evaluation of a transit compartment model versus a lag time model for describing drug absorption delay. Population Approach Group Europe: Uppsala, Sweden, 513 (2004).

V. K. Piotrovskii. The use of Weibull distribution to describe the in vivo absorption kinetics. Journal of pharmacokinetics and biopharmaceutics 15, 681–686 (1987).

R. M. Savic, D. M. Jonker, T. Kerbusch and M. O. Karlsson. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. Journal of pharmacokinetics and pharmacodynamics 34, 711–726 (2007).

H. White. Maximum Likelihood Estimation of Misspecified Models. Econometrica 50, 1–25 (1982).

B. Efron. Bootstrap Methods: Another Look at the Jackknife. The Annals of Statistics 7, 1–26 (1979).

A.-G. Dosne, M. Bergstrand, K. Harling and M. O. Karlsson. Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling. Journal of pharmacokinetics and pharmacodynamics 43, 583–596 (2016).

S. D. Patterson and B. Jones. Bioequivalence and statistics in clinical pharmacology. CRC Press (2017).

S.-C. Chow and J.-P. Liu. Design and analysis of bioavailability and bioequivalence studies. CRC press (2008).

X. Y. Lawrence and B. V. Li. FDA bioequivalence standards. Springer (2014).